United States Immuno-Oncology Market Report & Forecast 2021-2027

Publisher Name :
Date: 16-Sep-2021
No. of pages: 91
Inquire Before Buying

United States Immuno-Oncology Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Immuno-Oncology Market Segment Percentages, By Type, 2020 (%)

- Immune Checkpoint Inhibitors

- Cytokine-Based Immunotherapy

- Cancer Vaccines

- CAR-T Cell Therapy

- Others

United States Immuno-Oncology Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Immuno-Oncology Market Segment Percentages, By Application, 2020 (%)

- Hospitals

- Drugstores

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immuno-Oncology revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Immuno-Oncology revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Bristol-Myers Squibb

- Merck & Co., Inc.

- Roche AG

- AstraZeneca, Plc

- Sanofi S.A.

- Dendreon Pharmaceuticals

- Novartis

- Gilead Sciences Inc.

- Merck KGaA

United States Immuno-Oncology Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Immuno-Oncology Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Immuno-Oncology Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Immuno-Oncology Overall Market Size
2.1 United States Immuno-Oncology Market Size: 2021 VS 2027
2.2 United States Immuno-Oncology Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-Oncology Players in United States Market
3.2 Top United States Immuno-Oncology Companies Ranked by Revenue
3.3 United States Immuno-Oncology Revenue by Companies
3.4 Top 3 and Top 5 Immuno-Oncology Companies in United States Market, by Revenue in 2020
3.5 Companies Immuno-Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Oncology Players in United States Market
3.6.1 List of Tier 1 Immuno-Oncology Companies in United States
3.6.2 List of Tier 2 and Tier 3 Immuno-Oncology Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Immuno-Oncology Market Size Markets, 2021 & 2027
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Cytokine-Based Immunotherapy
4.1.4 Cancer Vaccines
4.1.5 CAR-T Cell Therapy
4.1.6 Others
4.2 By Type - United States Immuno-Oncology Revenue & Forecasts
4.2.1 By Type - United States Immuno-Oncology Revenue, 2016-2021
4.2.2 By Type - United States Immuno-Oncology Revenue, 2022-2027
4.2.3 By Type - United States Immuno-Oncology Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Immuno-Oncology Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - United States Immuno-Oncology Revenue & Forecasts
5.2.1 By Application - United States Immuno-Oncology Revenue, 2016-2021
5.2.2 By Application - United States Immuno-Oncology Revenue, 2022-2027
5.2.3 By Application - United States Immuno-Oncology Revenue Market Share, 2016-2027
6 Immuno-Oncology Companies Profiles
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Company Details
6.1.2 Bristol-Myers Squibb Business Overview
6.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
6.1.4 Bristol-Myers Squibb Immuno-Oncology Revenue in United States Market (2016-2021)
6.1.5 Bristol-Myers Squibb Recent Developments
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Company Details
6.2.2 Merck & Co., Inc. Business Overview
6.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
6.2.4 Merck & Co., Inc. Immuno-Oncology Revenue in United States Market (2016-2021)
6.2.5 Merck & Co., Inc. Recent Developments
6.3 Roche AG
6.3.1 Roche AG Company Details
6.3.2 Roche AG Business Overview
6.3.3 Roche AG Immuno-Oncology Introduction
6.3.4 Roche AG Immuno-Oncology Revenue in United States Market (2016-2021)
6.3.5 Roche AG Recent Developments
6.4 AstraZeneca, Plc
6.4.1 AstraZeneca, Plc Company Details
6.4.2 AstraZeneca, Plc Business Overview
6.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
6.4.4 AstraZeneca, Plc Immuno-Oncology Revenue in United States Market (2016-2021)
6.4.5 AstraZeneca, Plc Recent Developments
6.5 Sanofi S.A.
6.5.1 Sanofi S.A. Company Details
6.5.2 Sanofi S.A. Business Overview
6.5.3 Sanofi S.A. Immuno-Oncology Introduction
6.5.4 Sanofi S.A. Immuno-Oncology Revenue in United States Market (2016-2021)
6.5.5 Sanofi S.A. Recent Developments
6.6 Dendreon Pharmaceuticals
6.6.1 Dendreon Pharmaceuticals Company Details
6.6.2 Dendreon Pharmaceuticals Business Overview
6.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
6.6.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue in United States Market (2016-2021)
6.6.5 Dendreon Pharmaceuticals Recent Developments
6.7 Novartis
6.7.1 Novartis Company Details
6.7.2 Novartis Business Overview
6.7.3 Novartis Immuno-Oncology Introduction
6.7.4 Novartis Immuno-Oncology Revenue in United States Market (2016-2021)
6.7.5 Novartis Recent Developments
6.8 Gilead Sciences Inc.
6.8.1 Gilead Sciences Inc. Company Details
6.8.2 Gilead Sciences Inc. Business Overview
6.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
6.8.4 Gilead Sciences Inc. Immuno-Oncology Revenue in United States Market (2016-2021)
6.8.5 Gilead Sciences Inc. Recent Developments
6.9 Merck KGaA
6.9.1 Merck KGaA Company Details
6.9.2 Merck KGaA Business Overview
6.9.3 Merck KGaA Immuno-Oncology Introduction
6.9.4 Merck KGaA Immuno-Oncology Revenue in United States Market (2016-2021)
6.9.5 Merck KGaA Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Immuno-Oncology Market Opportunities & Trends in United States Market
Table 2. Immuno-Oncology Market Drivers in United States Market
Table 3. Immuno-Oncology Market Restraints in United States Market
Table 4. Key Players of Immuno-Oncology in United States Market
Table 5. Top Immuno-Oncology Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Immuno-Oncology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Immuno-Oncology Revenue Share by Companies, 2016-2021
Table 8. Companies Immuno-Oncology Product Type
Table 9. List of Tier 1 Immuno-Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Immuno-Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Immuno-Oncology Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Immuno-Oncology Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Immuno-Oncology Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Immuno-Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Immuno-Oncology Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Immuno-Oncology Revenue (US$, Mn), 2022-2027
Table 17. Bristol-Myers Squibb Company Details
Table 18. Bristol-Myers Squibb Business Overview
Table 19. Bristol-Myers Squibb Immuno-Oncology Product
Table 20. Bristol-Myers Squibb Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Bristol-Myers Squibb Recent Developments
Table 22. Merck & Co., Inc. Company Details
Table 23. Merck & Co., Inc. Business Overview
Table 24. Merck & Co., Inc. Immuno-Oncology Product
Table 25. Merck & Co., Inc. Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Merck & Co., Inc. Recent Developments
Table 27. Roche AG Company Details
Table 28. Roche AG Business Overview
Table 29. Roche AG Immuno-Oncology Product
Table 30. Roche AG Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Roche AG Recent Developments
Table 32. AstraZeneca, Plc Company Details
Table 33. AstraZeneca, Plc Business Overview
Table 34. AstraZeneca, Plc Immuno-Oncology Product
Table 35. AstraZeneca, Plc Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. AstraZeneca, Plc Recent Developments
Table 37. Sanofi S.A. Company Details
Table 38. Sanofi S.A. Business Overview
Table 39. Sanofi S.A. Immuno-Oncology Product
Table 40. Sanofi S.A. Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Sanofi S.A. Recent Developments
Table 42. Dendreon Pharmaceuticals Company Details
Table 43. Dendreon Pharmaceuticals Business Overview
Table 44. Dendreon Pharmaceuticals Immuno-Oncology Product
Table 45. Dendreon Pharmaceuticals Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Dendreon Pharmaceuticals Recent Developments
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Immuno-Oncology Product
Table 50. Novartis Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Novartis Recent Developments
Table 52. Gilead Sciences Inc. Company Details
Table 53. Gilead Sciences Inc. Business Overview
Table 54. Gilead Sciences Inc. Immuno-Oncology Product
Table 55. Gilead Sciences Inc. Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Gilead Sciences Inc. Recent Developments
Table 57. Merck KGaA Company Details
Table 58. Merck KGaA Business Overview
Table 59. Merck KGaA Immuno-Oncology Product
Table 60. Merck KGaA Immuno-Oncology Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Merck KGaA Recent Developments
List of Figures
Figure 1. Immuno-Oncology Segment by Type
Figure 2. Immuno-Oncology Segment by Application
Figure 3. United States Immuno-Oncology Market Overview: 2020
Figure 4. United States Immuno-Oncology Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Immuno-Oncology Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Immuno-Oncology Revenue in 2020
Figure 7. By Type - United States Immuno-Oncology Revenue Market Share, 2016-2027
Figure 8. By Application - United States Immuno-Oncology Revenue Market Share, 2016-2027
Figure 9. Bristol-Myers Squibb Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Merck & Co., Inc. Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Roche AG Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. AstraZeneca, Plc Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Sanofi S.A. Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Dendreon Pharmaceuticals Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Novartis Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Gilead Sciences Inc. Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Merck KGaA Immuno-Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs